Alkem Laboratories
| Company type | Public |
|---|---|
| BSE: 539523 NSE: ALKEM | |
| Industry | Pharmaceuticals |
| Founded | 1973 |
| Founder | Samprada Singh |
| Headquarters | , India |
| Products | |
| Revenue | ₹10,634 crore (US$1.3 billion) (2024) |
| ₹2,052 crore (US$240 million) (2022) | |
| ₹1,645 crore (US$190 million) (2024) | |
| Total assets | ₹14,069 crore (US$1.7 billion) (2024) |
| Total equity | ₹8,637 crore (US$1.0 billion) (2024) |
| Owner | The Singh Family |
Number of employees | 20,000 (2024) |
| Subsidiaries | Pharmacor Limited, Ascend, Cachet, Enzene, Indchemie, Connect2clinic, Alkem Foundation |
| Website | www |
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai,India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets.